Article info

Download PDFPDF
Original article
HBsAg seroclearance after nucleoside analogue therapy in patients with chronic hepatitis B: clinical outcomes and durability

Authors

  1. Correspondence to Professor Young-Suk Lim, Department of Gastroenterology, Asan Medical Center, 88, Olympic-ro 43-gil, Songpa-gu, Seoul 138-736, Republic of Korea; limys{at}amc.seoul.kr
View Full Text

Citation

Kim G, Lim Y, An J, et al
HBsAg seroclearance after nucleoside analogue therapy in patients with chronic hepatitis B: clinical outcomes and durability

Publication history

  • Received June 25, 2013
  • Revised October 4, 2013
  • Accepted October 5, 2013
  • First published October 25, 2013.
Online issue publication 
July 08, 2014

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.